Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Long-Lasting Remission in De Novo Breast Myeloid Sarcoma Treated with Decitabine and Radiotherapy.

Minoia C, de Fazio V, Scognamillo G, Scattone A, Maggialetti N, Ferrari C, Guarini A.

Diagnostics (Basel). 2019 Jul 27;9(3). pii: E84. doi: 10.3390/diagnostics9030084.

2.

Effects of Physical Exercise Intervention on Psychological and Physical Fitness in Lymphoma Patients.

Fischetti F, Greco G, Cataldi S, Minoia C, Loseto G, Guarini A.

Medicina (Kaunas). 2019 Jul 16;55(7). pii: E379. doi: 10.3390/medicina55070379.

3.

1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia.

Daniele G, L'Abbate A, Turchiano A, Palumbo O, Carella M, Lo Cunsolo C, Iuzzolino P, Lonoce A, Hernández-Sánchez M, Minoia C, Leone P, Hernandez-Rivas JM, Storlazzi CT.

Clin Exp Med. 2019 May;19(2):261-267. doi: 10.1007/s10238-019-00551-0. Epub 2019 Mar 15.

PMID:
30877410
4.

Scheduled intermittent inotropes for Ambulatory Advanced Heart Failure. The RELEVANT-HF multicentre collaboration.

Oliva F, Perna E, Marini M, Nassiacos D, Cirò A, Malfatto G, Morandi F, Caico I, Perna G, Meloni S, Vincenzi A, Villani A, Vecchi AL, Minoia C, Verde A, De Maria R; RELEVANT-HF study group.

Int J Cardiol. 2018 Dec 1;272:255-259. doi: 10.1016/j.ijcard.2018.08.048. Epub 2018 Aug 16.

PMID:
30131229
5.

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.

Federico M, Caballero Barrigón MD, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Álvarez S, Wondergem M, Cartron G, Lopez-Guillermo A, Issa D, Morschhauser F, Alcoceba M, Kimby E, Rusconi C, Chamuleau M, Holte H, Lockmer S, Montoto S, Gomes da Silva M, Aurer I, Zucca E, Paszkiewicz-Kozik E, Minoia C, Skrypets T, Blaker YN, Salles G, Coiffier B; Aristotle Consortium.

Lancet Haematol. 2018 Aug;5(8):e359-e367. doi: 10.1016/S2352-3026(18)30090-5. Epub 2018 Jul 4.

PMID:
30078408
6.

Improvable Lifestyle Factors in Lymphoma Survivors.

Minoia C, Ciavarella S, Lerario G, Daniele A, De Summa S, Napolitano M, Guarini A.

Acta Haematol. 2018;139(4):235-237. doi: 10.1159/000489252. Epub 2018 Jun 21. No abstract available.

PMID:
29929199
7.

Novel acquisitions on biology and management of transformed follicular lymphoma.

Minoia C, Zucca E, Conconi A.

Hematol Oncol. 2018 Oct;36(4):617-623. doi: 10.1002/hon.2508. Epub 2018 Mar 30. Review.

PMID:
29602222
8.

Incidence, predictors, and impact on outcome of increased left ventricular latency in patients undergoing cardiac resynchronization therapy.

D'Onofrio A, Caico SI, Iuliano A, Pieragnoli P, Bianchi V, Orsida D, Pani A, Pasqualini M, Amadori F, Vasquez L, Talarico A, Minoia C, Ospizio R, Merlotti G, Malacrida M, Stabile G.

J Interv Card Electrophysiol. 2018 Apr;51(3):245-252. doi: 10.1007/s10840-018-0321-7. Epub 2018 Mar 3.

PMID:
29502194
9.

Risk of lymphoma subtypes by occupational exposure in Southern Italy.

Ferri GM, Specchia G, Mazza P, Ingravallo G, Intranuovo G, Guastadisegno CM, Congedo ML, Lagioia G, Loparco MC, Giordano A, Perrone T, Guadio F, Spinosa C, Minoia C, D'Onghia L, Strusi M, Corrado V, Cavone D, Vimercati L, Schiavulli N, Cocco P.

J Occup Med Toxicol. 2017 Nov 23;12:31. doi: 10.1186/s12995-017-0177-2. eCollection 2017.

10.

Improving Provision of Care for Long-term Survivors of Lymphoma.

Ciavarella S, Minoia C, Quinto AM, Oliva S, Carbonara S, Cormio C, Cox MC, Bravo E, Santoro F, Napolitano M, Spina M, Loseto G, Guarini A.

Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e1-e9. doi: 10.1016/j.clml.2017.08.097. Epub 2017 Aug 17. Review.

PMID:
28916153
11.

Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.

Puccini B, Nassi L, Minoia C, Volpetti S, Ciancia R, Riccomagno PC, Di Rocco A, Mulè A, Toldo C, Sassone MC, Guariglia R, Filì C, Finolezzi E, Falorio S, Zanon S, Furlan A, Doa G, Zaja F; Fondazione Italiana Linfomi Postgraduate Master course.

Ann Hematol. 2017 Jul;96(7):1147-1153. doi: 10.1007/s00277-017-2996-8. Epub 2017 Apr 28.

PMID:
28451805
12.

u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression.

Ciavarella S, Laurenzana A, De Summa S, Pilato B, Chillà A, Lacalamita R, Minoia C, Margheri F, Iacobazzi A, Rana A, Merchionne F, Fibbi G, Del Rosso M, Guarini A, Tommasi S, Serratì S.

BMC Cancer. 2017 Mar 24;17(1):215. doi: 10.1186/s12885-017-3183-y.

13.

Two weeks at Harvard, for two European heart failure trainees.

Minoia C, Paolillo S.

Eur Heart J. 2016 Dec 21;37(48):3553-3554. doi: 10.1093/eurheartj/ehw554. No abstract available.

PMID:
28087746
14.

The ESC Heart Failure Association postgraduate course in heart failure.

Paolillo S, Minoia C.

Eur Heart J. 2016 Dec 21;37(48):3551-3552. doi: 10.1093/eurheartj/ehw553. No abstract available.

PMID:
28087745
15.

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.

Pozzi S, Gentile M, Sacchi S, Marcheselli R, Corso A, Cocito F, Musto P, Guarini A, Minoia C, Vincelli I, Ria R, Rivolti E, Mele G, Bari A, Mazzone C, Badiali S, Marcheselli L, Palumbo A, Morabito F.

Leuk Lymphoma. 2017 Mar;58(3):552-559. doi: 10.1080/10428194.2016.1205741. Epub 2016 Jul 21.

PMID:
27442600
16.

Can diffusion-weighed whole-body magnetic resonance imaging with body signal suppression play a role in the management of lymphoma patients?

Minoia C, Maggialetti N, Ferrari C, Brunese L, Rubini G, Guarini A.

J BUON. 2016 Jan-Feb;21(1):282-3. No abstract available.

17.

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients.

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G.

Bone Marrow Transplant. 2016 Jul;51(7):1002-3. doi: 10.1038/bmt.2016.29. Epub 2016 Mar 7. No abstract available.

PMID:
26950381
18.

The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).

Mazza P, Minoia C, Melpignano A, Polimeno G, Cascavilla N, Di Renzo N, Specchia G.

Ann Hematol. 2016 Jan;95(2):239-44. doi: 10.1007/s00277-015-2556-z. Epub 2015 Nov 24.

PMID:
26596973
19.

Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination.

Malandrino P, Russo M, Ronchi A, Minoia C, Cataldo D, Regalbuto C, Giordano C, Attard M, Squatrito S, Trimarchi F, Vigneri R.

Endocrine. 2016 Aug;53(2):471-9. doi: 10.1007/s12020-015-0761-0. Epub 2015 Oct 5.

PMID:
26438396
20.

Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.

Maggialetti N, Ferrari C, Minoia C, Asabella AN, Ficco M, Loseto G, De Tullio G, de Fazio V, Calabrese A, Guarini A, Rubini G, Brunese L.

Radiol Med. 2016 Feb;121(2):132-43. doi: 10.1007/s11547-015-0581-6. Epub 2015 Sep 9.

PMID:
26349573
21.

Impact of novel agents followed by autologous hematopoietic stem cell transplantation for multiple myeloma patients aged 65 years or older: a retrospective single Institutional analysis.

Minoia C, Pisapia G, Palazzo G, Ingrosso C, Buonanno M, Spinosa C, Prudenzano A, Pricolo G, Mazza P.

Bone Marrow Transplant. 2015 Nov;50(11):1486. doi: 10.1038/bmt.2015.185. Epub 2015 Aug 17. No abstract available.

PMID:
26281030
22.

"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese".

Mele G, Melpignano A, Quarta G, Palumbo G, Capalbo S, Falcone A, Cascavilla N, Palazzo G, Mazza P, Iannitto E, Curci P, Rizzi R, Specchia G, Rossini B, Pavone V, Ria R, Vacca A, Buquicchio C, Tarantini G, Minoia C, Guarini A, Ditonno P, Polimeno G, Reddiconto G, Di Renzo N.

Leuk Res. 2015 Mar;39(3):279-83. doi: 10.1016/j.leukres.2014.12.007. Epub 2014 Dec 23.

PMID:
25636354
23.

Azacitidine in the front-line treatment of therapy-related myeloid neoplasms: a multicenter case series.

Minoia C, Sgherza N, Loseto G, Greco G, Buquicchio C, Merchionne F, Toldo C, Galise I, Melpignano A, Tarantini G, Pavone V, Guarini A.

Anticancer Res. 2015 Jan;35(1):461-6.

PMID:
25550588
24.

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis.

Merchionne F, Quintana G, Gaudio F, Minoia C, Specchia G, Guarini A, Quarta G, Pavone V, Melpignano A.

Leuk Res. 2014 Dec;38(12):1446-50. doi: 10.1016/j.leukres.2014.10.001. Epub 2014 Oct 22.

PMID:
25455656
25.

Challenges and opportunities of microRNAs in lymphomas.

De Tullio G, De Fazio V, Sgherza N, Minoia C, Serratì S, Merchionne F, Loseto G, Iacobazzi A, Rana A, Petrillo P, Silvestris N, Iacopino P, Guarini A.

Molecules. 2014 Sep 17;19(9):14723-81. doi: 10.3390/molecules190914723. Review.

26.

[Studies on markers of exposure and early effect in areas with arsenic pollution: methods and results of the project SEpiAs. Epidemiological surveillance in areas with environmental pollution by natural or anthropogenic arsenic].

Bustaffa E, Minichilli F, Andreassi MG, Carone S, Coi A, Cori L, Faita F, Faita F, Grecchi S, Minoia C, Ronchi A, Scovassi I, Sicari R, Stea F, Bianchi F; Gruppo di lavoro SEpiAS.

Epidemiol Prev. 2014 May-Aug;38(3-4 Suppl 1):27-94. Italian.

27.

FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities.

L'Abbate A, Lo Cunsolo C, Macrì E, Iuzzolino P, Mecucci C, Doglioni C, Coco M, Muscarella LA, Salati S, Tagliafico E, Minoia C, De Tullio G, Guarini A, Testoni N, Agostinelli C, Storlazzi CT.

BMC Cancer. 2014 Jun 3;14:396. doi: 10.1186/1471-2407-14-396.

28.
29.

Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.

Ferrari C, Minoia C, Asabella AN, Nicoletti A, Altini C, Antonica F, Ficco M, Guarini A, Maggialetti N, Rubini G.

Hell J Nucl Med. 2014 Jan-Apr;17 Suppl 1:40-9.

PMID:
24392468
30.

Allergological and toxicological aspects in a multiple chemical sensitivity cohort.

Pigatto PD, Minoia C, Ronchi A, Brambilla L, Ferrucci SM, Spadari F, Passoni M, Somalvico F, Bombeccari GP, Guzzi G.

Oxid Med Cell Longev. 2013;2013:356235. doi: 10.1155/2013/356235. Epub 2013 Dec 3.

31.

Arsenic exposure triggers a shift in microRNA expression.

Sturchio E, Colombo T, Boccia P, Carucci N, Meconi C, Minoia C, Macino G.

Sci Total Environ. 2014 Feb 15;472:672-80. doi: 10.1016/j.scitotenv.2013.11.092. Epub 2013 Dec 7.

PMID:
24317173
32.

HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target.

Ria R, Catacchio I, Berardi S, De Luisi A, Caivano A, Piccoli C, Ruggieri V, Frassanito MA, Ribatti D, Nico B, Annese T, Ruggieri S, Guarini A, Minoia C, Ditonno P, Angelucci E, Derudas D, Moschetta M, Dammacco F, Vacca A.

Clin Cancer Res. 2014 Feb 15;20(4):847-58. doi: 10.1158/1078-0432.CCR-13-1950. Epub 2013 Dec 2.

33.

Changes in angiogenesis and hypoxia-inducible factor-1α protein expression in relapsed/refractory indolent non-Hodgkin lymphomas.

Minoia C, Quero C, Asselti M, Galise I, Marzano AL, Iacobazzi A, Rana A, Merchionne F, Serratì S, De Tullio G, Quintana G, Casiello M, Maiorano E, Simone G, Zito FA, Iacopino P, Guarini A.

Br J Haematol. 2013 Dec;163(5):640-5. doi: 10.1111/bjh.12560. Epub 2013 Sep 13.

PMID:
24033233
34.

Targeted strategies in the treatment of primary gastric lymphomas: from rituximab to recent insights into potential new drugs.

Merchionne F, Iacopino P, Minoia C, Iacobazzi A, Rana A, Serrati S, De Tullio G, Loseto G, Lapietra A, Lucarelli A, Guarini A.

Curr Med Chem. 2014;21(8):1005-16. Review.

PMID:
23992322
35.

Exposure to priority organochlorine contaminants in the Italian general population. Part 1. Eight priority organochlorinated pesticides in blood serum.

Mrema EJ, Rubino FM, Mandic-Rajcevic S, Sturchio E, Turci R, Osculati A, Brambilla G, Minoia C, Colosio C.

Hum Exp Toxicol. 2013 Dec;32(12):1323-39. doi: 10.1177/0960327113485255. Epub 2013 Jul 15.

PMID:
23857032
36.

Exposure to priority organochlorine contaminants in the Italian general population. Part 2: Fifteen priority polychlorinated biphenyl congeners in blood serum.

Mrema EJ, Rubino FM, Mandic-Rajcevic S, Sturchio E, Turci R, Osculati A, Brambilla G, Minoia C, Colosio C.

Hum Exp Toxicol. 2014 Feb;33(2):170-84. doi: 10.1177/0960327113485256. Epub 2013 Jul 15.

PMID:
23857031
37.

[Determination of persistent organic compounds in serum by using gas chromatography coupled with triple quadrupole mass spectrometry].

Turci R, Businaro J, Poma P, Minoia C.

G Ital Med Lav Ergon. 2012 Jul-Sep;34(3 Suppl):674-7. Italian.

PMID:
23405749
38.

[Reference values for 42 trace elements in biological fluids (database RE-VA)].

Minoia C, Ronchi A, Businaro J, Poma P, Turci R.

G Ital Med Lav Ergon. 2012 Jul-Sep;34(3 Suppl):651-4. Italian.

PMID:
23405742
39.

[Possible use of microRNAs as biomarkers for monitoring of workers exposed to asbestos].

Sturchio E, Amadori A, Businaro J, Ficociello B, Ferrazza P, Colosio C, Minoia C.

G Ital Med Lav Ergon. 2012 Jul-Sep;34(3 Suppl):571-3. Italian.

PMID:
23405719
40.

[Antineoplastic profile assessment for the evaluation of occupational exposure in hospital personnel involved in handling cytotoxic agents].

Sottani C, Fugnoli L, Businaro J, Poma P, Ronchi A, Micoli G, Minoia C.

G Ital Med Lav Ergon. 2012 Jul-Sep;34(3 Suppl):294-8. Italian.

PMID:
23405646
41.

Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE.

Sottani C, Poggi G, Melchiorre F, Montagna B, Minoia C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Feb 1;915-916:71-8. doi: 10.1016/j.jchromb.2012.12.012. Epub 2012 Dec 22.

PMID:
23337906
42.

Human placenta and markers of heavy metals exposure.

Pigatto PD, Minoia C, Ronchi A, Guzzi G.

Environ Health Perspect. 2013 Jan;121(1):A10. doi: 10.1289/ehp.1206061. No abstract available.

43.

Complete response to second line Paclitaxel every 2 weeks of eyelid kaposi sarcoma: a case report.

Brunetti AE, Guarini A, Lorusso V, Minoia C, Sabatelli A, Marech I, Silvestris N.

Ophthalmic Plast Reconstr Surg. 2013 Sep-Oct;29(5):e114-5. doi: 10.1097/IOP.0b013e3182776f32.

PMID:
23247036
44.

Serum concentrations of persistent organic pollutants (POPs) in the inhabitants of a Sicilian city.

Amodio E, Turci R, Massenti MF, Di Gaudio F, Minoia C, Vitale F, Firenze A, Calamusa G.

Chemosphere. 2012 Nov;89(8):970-4. doi: 10.1016/j.chemosphere.2012.06.054. Epub 2012 Jul 26.

PMID:
22840540
45.

Antineoplastic drug-induced bradyarrhythmias.

Minoia C, Giannoccaro M, Iacobazzi A, Santini D, Silvestris N, Fioretti A, Oliva S, Guarini A.

Expert Opin Drug Saf. 2012 Sep;11(5):739-51. doi: 10.1517/14740338.2012.705826. Epub 2012 Jul 13. Review.

PMID:
22788850
46.

Serum pharmacokinetics in patients treated with transarterial chemoembolization (TACE) using two types of epirubicin-loaded microspheres.

Sottani C, Poggi G, Quaretti P, Regazzi M, Montagna B, Quaquarini E, Imbriani M, Leoni E, Di Cesare P, Riccardi A, Bernardo G, Minoia C.

Anticancer Res. 2012 May;32(5):1769-74.

PMID:
22593459
47.

Mercury amalgam exposure: assessment of risks in US after the year 2000.

Guzzi G, Ronchi A, Pigatto PD, Minoia C.

Sci Total Environ. 2012 Oct 1;435-436:584; author reply 583. doi: 10.1016/j.scitotenv.2012.03.061. Epub 2012 Apr 25. No abstract available.

PMID:
22542228
48.

[microRNAs as biological indicators of environmental and occupational exposure to asbestos].

Minoia C, Sturchio E, Porro B, Ficociello B, Zambelli A, Imbriani M.

G Ital Med Lav Ergon. 2011 Oct-Dec;33(4):420-34. Review. Italian.

PMID:
22452101
49.

Farmers' exposure to herbicides in North Italy: assessment under real-life conditions in small-size rice and corn farms.

Rubino FM, Mandic-Rajcevic S, Ariano E, Alegakis A, Bogni M, Brambilla G, De Paschale G, Firmi A, Minoia C, Micoli G, Savi S, Sottani C, Somaruga C, Turci R, Vellere F, Tsatsakis A, Colosio C.

Toxicol Lett. 2012 Apr 25;210(2):189-97. doi: 10.1016/j.toxlet.2012.01.017. Epub 2012 Jan 28.

PMID:
22306369
50.

mTOR as a target of everolimus in refractory/relapsed Hodgkin lymphoma.

Guarini A, Minoia C, Giannoccaro M, Rana A, Iacobazzi A, Lapietra A, Raimondi A, Silvestris N, Gadaleta CD, Ranieri G.

Curr Med Chem. 2012;19(7):945-54. Review.

PMID:
22214465

Supplemental Content

Loading ...
Support Center